VAERS reports by lot

Novartis Vaccines Meningococcal lot KL472: VAERS reports

21 VAERS reports list lot KL472 as a Novartis Vaccines Meningococcal vaccine, received between 2022-09-06 and 2024-07-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological624%
Injection-site / Local reaction520%
General / Systemic (non-local)416%
Gastrointestinal312%
Musculoskeletal312%
Allergic / Anaphylactic28%
Cardiac / Cardiovascular14%
Respiratory14%

Where reports came from

U.S. state of the reporter, where given (top 10).

Virginia3
Pennsylvania2
Michigan2
California2
North Carolina1
Illinois1
Minnesota1
Florida1
Kentucky1
New York1

Reports by month received

2022-093
2022-122
2023-016
2023-023
2023-031
2023-041
2023-061
2023-071
2023-081
2023-111
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.